Browse All

Current Filters

CLEAR FILTER x

TITLE

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results

Author:Goyal, Namita A.   Machado, Pedro M.   Ascherman, Dana P.   Benveniste, Olivier   Beydoun, Said R.   Brannagan, Thomas H.   Christopher-Stine, Lisa   Collins, Michael P.   De Bleecker, Jan L.   Dimachkie, Mazen   Dixon, Stacy   Fernandez, David R.   Freimer, Miriam   Geiger, Christopher   Gonzalez-Perez, Paloma   Goyal, Neelam   Gwathmey, Kelly   Heitzman, Daragh   Henderson, Robert D.   Hodson-Webb, Lisa D.   Hussain, Yessar   Korngut, Lawrence   Liang, Christina   Lilleker, James B.   Lloyd, Thomas   Mohassel, Payam   Naddaf, Elie   Needham, Merrilee   Piccione, Ezequiel   Quinn, Colin C.   Rosow, Laura   Roy, Bhaskar   Ruck, Tobias   Schmidt, Jens   Seth, Arjun   Shah, Jaimin   Shaibani, Aziz   Shieh, Perry B.   Simmons, Zachary   Sivakumar, Kumaraswamy   Wang, Leo H.   Weihl, Conrad C.   Wilkins, H. Jeffrey   Amato, Anthony   

Session Name:S7: Updates on Muscle Disorders  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S7.007  

Author Institution:

Exploring Demographic and Racioethnic Determinants of Phenotype and Treatment Response in Anti-HMGCR Myopathy

Author:Seyam, Muhannad   Goyal, Neelam   Chaitesipaseut, Lena   Spahn, Claire   Muppidi, Srikanth   

Session Name:P8: Neuromuscular and Clinical Neurophysiology (EMG): Muscle Disorders  

Topic:Movement Disorders  

Program Number:P8.019  

Author Institution:

Assessing Glucocorticoid Associated Toxicity in Myasthenia Gravis Using the Glucocorticoid Toxicity Index

Author:Beaudin, Marie   Hailu, Raiye   Yaworski, Amanda   Muppidi, Srikanth   Goyal, Neelam   

Session Name:P11: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Treatments  

Topic:Infectious Disease  

Program Number:P11.002  

Author Institution: